John Uri Lloyd

John Uri Lloyd (1849—1936) was the eclectic pharmacist whose pharmaceutical manufacturing, chemical research, and library building gave the eclectic medical movement its most durable institutional legacy. As partner at what became Lloyd Brothers Pharmacists, he manufactured the specific medicines that John Milton Scudder had developed and ensured their quality control. His chemical research in plant pharmacy anticipated discoveries in colloidal chemistry. He built the Lloyd Library in Cincinnati into a collection that surpassed even the Library of the Surgeon-General in its holdings on reform medicine, and which survives today as the Lloyd Library and Museum. Most importantly for the history of botanical medicine, Lloyd articulated an early and forceful defense of whole-plant therapeutics against the dominant trend toward isolated active principles.

Life and Context

Lloyd was born on April 19, 1849, in West Bloomfield, Ontario County, New York, to Nelson M. Lloyd (Flannery, 1998). His parents chose a pharmacy apprenticeship over college for him, believing that beginning at the bottom of a practical trade was essential and that college might divert him from his vocation (Flannery, 1998). In 1863–1864, when Lloyd and his father searched Cincinnati for an apprenticeship, the druggist Mr. Gordon warned them away from H. M. Merrell’s eclectic drugstore, telling them that the affiliation would “destroy your future” because the house was “not in good standing” and “without professional affiliations” (Flannery, 1998). Prior to the Civil War, formal pharmacy education in the United States was extremely limited; by century’s end only 12 percent of practicing pharmacists had training beyond apprenticeship (Flannery, 1998).

Haller identifies him as “by far the most famous of the school’s faculty” at the Eclectic Medical Institute, where he served as professor of chemistry and pharmacy (Haller, 1999). He held the chair of Chemistry and Pharmacy at EMI for seventeen years, from 1878 to 1895, and also taught at the Cincinnati College of Pharmacy for four years (Caswell A. Mayo / Corinne Miller Simons, 1894).

Lloyd’s decision to ally with eclecticism came at a cost. Drs. King and Scudder warned him that the affiliation would subject him to professional ostracism, and it did. Yet his research contributions were strong enough to earn him the presidency of the American Pharmaceutical Association in 1887 — a remarkable honor for someone working outside the regular medical establishment (Caswell A. Mayo / Corinne Miller Simons, 1894).

Lloyd outlived the Eclectic Trinity.(Haller, 1994)(Haller, 1994) After Howe, King, and Scudder passed away, Haller writes in both Medical Protestants (1994) and A Profile in Alternative Medicine (1999) that only Lloyd remained to carry on the cause of reform medicine.(Haller, 1994)(Haller, 1994) In the final decades of the EMI’s existence, Haller records, Lloyd became the college’s chief financial benefactor, pledging ten thousand dollars annually and later increasing that pledge to fifty thousand.(Haller, 1994)

Core Contributions

Pharmaceutical Manufacturing and Specific Medicines

John Uri Lloyd, dubbed “the wizard of American plant pharmacy and chemistry,” was the principal manufacturer of eclectic medicines through his firm Lloyd Brothers.(Haller, 1994) Scudder ensured quality control of his specific medicines by turning their manufacture over to Merrell.(Haller, 1999) Haller records that Lloyd Brothers manufactured specific medicines in standard square bottles of four, eight, and sixteen ounces, each labeled with the indications for the remedy and the recommended dosage.(Haller, 1994)

Wilder records that Lloyd’s pharmaceutical research provided the scientific basis for the eclectic materia medica into the twentieth century. Wilder goes further, arguing that the pharmaceutical innovations of Merrell and the Lloyd Brothers represented the eclectic school’s most enduring scientific contribution — plant chemistry that would eventually be incorporated into mainstream pharmacology even as the school itself declined.

Specific Medicines were highly concentrated unofficial tinctures — approximately eight times the strength of most official tinctures — prepared from fresh plant material by maceration or percolation, following Scudder’s insistence on using “the fresh article before any desiccation.”(Flannery, 1998) By 1884 Thorp and Lloyd Brothers had grown to offer sixteen different product lines, including Specifics, fluidextracts, solid extracts, elixirs, syrups, and wines.(Flannery, 1998) Lloyd expanded the fluidextract line from 176 to 835 preparations between 1878 and 1884, while competitor Parke Davis had only 494 in 1885.(Flannery, 1998)

Haller records a detail that shows the commercial resilience of eclectic pharmacy: when the First World War disrupted American access to German synthetic drugs — prices for carbolic acid, salicylic acid, and potassium permanganate rising between 700 and 1,233 percent from August 1914 to November 1915 — Lloyd took what Haller calls “patriotic pride” in the fact that eclectic drug prices held comparatively stable, giving the school a temporary commercial advantage it had not anticipated.(Haller, 1994)

The motto vires vitales sustinete — sustain the vital forces — captured in Haller’s account the philosophical shift that Scudder’s specific medication represented. As Haller quotes Lloyd: “Small doses of kindly remedies, established by clinical study in disease, administered for curative action, not systemic shock, now universally prevail.” This statement, from the manufacturer whose products embodied the doctrine, is also a precise description of what distinguished eclectic pharmacy from both heroic dosing and from the commercial extract trade that had preceded it.(Haller, 1994)

Whole-Plant Synergy vs. Isolated Active Principles

Lloyd’s most lasting intellectual contribution was his early articulation of what is now called whole-plant synergy. Griggs records that Lloyd and his eclectic colleagues had learned “by bitter experience, that a poisonous fragment or ultimate, broken out of or created from a plant by chemistry, did not represent the therapeutic qualities of the structure from which it was derived.” Lloyd was always careful to distinguish this position from the orthodox method of extracting a single potent principle (Griggs, 1981).

The Lloyd brothers’ study of goldenseal, published in Drugs and Medicines of North America (1884–1885), was and remains one of the most detailed scientific investigations of that plant.(Flannery, 1998) In 1914, he protested against the widespread use of corrosive sublimate (mercury bichloride), condemning it as “perhaps the greatest scourge, the most monstrous drug enemy of the human race” and extending his criticism to “illogical serums, repulsive animal extracts, death-dealing arsenical compounds” and coal-tar synthetics (Griggs, 1981).

Chemical Research

Lloyd’s textbook The Chemistry of Medicines, first published in 1881, ran through eight editions by 1897 and was widely regarded as one of the first American textbooks on pharmaceutical chemistry written by a pharmacist.(Flannery, 1998) His 1883 book Elixirs: Their History, Formulae, and Methods of Preparation provided 283 formulas and served as a key impetus for the compilation of the first National Formulary.(Flannery, 1998) Lloyd performed the research Rice wanted for the sixth revision of the USP on condition that Professor Judge’s name appear and that Lloyd be unmentioned; historians of pharmacy considered that revision the most sweeping ever.(Flannery, 1998)

Lloyd’s landmark series “Precipitates in Fluid Extracts” (five papers, 1881—1885) identified five factors affecting precipitation — oxidation, solvent evaporation, temperature change, chemical change, and light — and won him his first Ebert Prize in 1882 (Flannery, 1998). His research in mass action, structural affinities, and contact reactions between 1879 and 1885 anticipated key discoveries in colloidal chemistry, a fact acknowledged by Wolfgang Ostwald, editor of the influential German journal Kolloidchemische Beihefte, who translated and republished Lloyd’s articles in 1916, praising them as containing “truly exemplary insight” with no equivalent “even in the handbooks and pharmacopoeia.” Historian George Urdang called this “one of the greatest tributes paid to an American scientist by European science” (Flannery, 1998). Ostwald stated directly that Lloyd’s studies of mass action, which Ostwald had caused to be translated and published in German, “in many particulars antedated his own work in that phase of colloidal chemistry, foreshadowing many of the discoveries and deductions made by later students in that fascinating field.”(Caswell A. Mayo / Corinne Miller Simons, 1894)

In the winter of 1910, Lloyd prepared a mixture of berberine sulphate and fullers’ earth that yielded an alkaloid-free filtrate, and he made arrangements for Eli Lilly to manufacture and market the reagent, hydrous aluminum silicate (Flannery, 1998). Lloyd also patented an apparatus for extracting substances without heat on December 13, 1904 (US Patent 777,115), and Remington’s Practice of Pharmacy included his extractor from 1926 to 1975 (Flannery, 1998).

The Lloyd Library

The Lloyd Library originated from the practical need to accumulate books on plant chemistry, pharmacy, and materia medica in order to carry out the research plans of Drs. King and Scudder (Caswell A. Mayo / Corinne Miller Simons, 1894). The library grew not from surplus wealth but from the self-education and penny-saving of three brothers who donated it as a free gift to the world of science (Caswell A. Mayo / Corinne Miller Simons, 1894). The entire expense of the library, its structures, and its maintenance was met exclusively by the three brothers (Caswell A. Mayo / Corinne Miller Simons, 1894). King donated his own professional library to the collection, significantly enriching its holdings (Caswell A. Mayo / Corinne Miller Simons, 1894).

Wilder, writing in 1904, recorded that Lloyd had assembled the most complete collection of publications by medical reformers of all schools, exceeding even the Library of the Surgeon-General at Washington (Wilder, 1904). The library catalogued more than eighty periodicals covering publications from every state where eclectic medicine was practiced, extending to England and Australia . The Eclectic Medical College’s uniquely complete institutional records — student files, faculty papers, board minutes — were eventually archived there as well (Haller, 1999).

Defender of General Practice

Lloyd used his institutional standing to argue against what he saw as the destructive professionalization of medicine. He defended EMI’s less demanding admission standards by arguing that the new AMA-approved curriculum would produce specialists while leaving rural areas without sufficient health providers, predicting that most families would be left to patent medicine advertisers.(Haller, 1999) Haller’s Medical Protestants (1994) records Lloyd’s specific proposal: to eliminate the terms “regular,” “irregular,” and “sectarian” entirely, replacing them with “dominant section” for regulars while retaining “eclectic” for reformers, arguing that accepting the term “regular” in the sense that everything outside it was irregular would “paralyze investigation, prohibit thought, circumscribe the individual’s opportunities and retard the world’s advancement.”(Haller, 1994) (Haller, 1994)

Lloyd championed the Pure Food and Drug Act of 1906 within eclectic circles, insisting through the Eclectic Medical Gleaner that no eclectic remedy contained secret narcotics or coal-tar synthetics and that none needed to change composition to comply.(Flannery, 1998)

In 1923, Lloyd and his brother Nelson Ashley purchased land near Bethesda Hospital for a new college building, and an ambitious $1,250,000 building-and-endowment campaign was launched, though it ultimately failed to materialize (Haller, 1999).

Legacy and Influence

Lloyd’s triple legacy — pharmaceutical manufacturing, chemical research, and library building — outlasted the eclectic movement itself. The Lloyd Library and Museum survives in Cincinnati as a major research archive for botanical, pharmaceutical, and medical history. The specific medicines manufactured by Lloyd Brothers defined eclectic therapeutic practice for decades. And Lloyd’s argument that whole-plant preparations have therapeutic properties not reducible to isolated chemical constituents continues to resonate in modern discussions of phytochemistry and herbal medicine.

The practical disposition of his pharmaceutical legacy, however, is a story with an unresolved ending. Haller records that two years after Lloyd’s death in 1936, the S.B. Penick Co. of New York purchased Lloyd Brothers Pharmacists Inc., promising to continue the brothers’ products and research. Shortly after the sale, Lloyd’s original drug-formula books disappeared. The trustees of his estate — Dean Nellans, Charles R. Campbell, and son John Thomas Lloyd — appear not to have transferred the formula books to the new company, and whether John Thomas Lloyd retained them privately remains unclear. Haller notes that the whereabouts of the formulas for Lloyd’s specific medicines remain a mystery.(Haller, 1994)

His career also illustrates a recurring tension in reform medicine: between maintaining distinctive principles and achieving the institutional respectability needed to survive in an increasingly standardized professional environment. Lloyd fought for eclectic survival on both fronts — insisting on the scientific validity of plant-based pharmacy while trying to meet (or resist) the rising admission and curricular standards that the AMA and the Flexner Report imposed on all medical schools.

Scholarly Assessment

Flannery’s John Uri Lloyd: The Great American Eclectic (1998) is the only dedicated biography and provides the fullest account of Lloyd’s early years, pharmaceutical innovations, scientific publications, and controversies. It documents his Ebert Prize, his colloidal chemistry research, and the trajectory of Lloyd’s reagent from accidental discovery to Eli Lilly product.

Haller, across three books, treats Lloyd as the last major figure of the eclectic movement and the person most responsible for preserving its material and documentary record. In A Profile in Alternative Medicine (1999), Lloyd appears as the faculty member who gave EMI its pharmaceutical credibility and who fought a losing rearguard action against standardization. In Medical Protestants (1994), Lloyd is the survivor who outlived the Eclectic Trinity and proposed terminological reforms that went unheeded. Griggs in Green Pharmacy (1981) gives Lloyd his most favorable treatment, presenting the whole-plant synergy argument as a genuine intellectual contribution that anticipated modern pharmacology. Wilder in History of Medicine (1904) wrote as a near-contemporary and treated Lloyd’s library and pharmaceutical work as the school’s greatest achievements. The Lloyd Library and its Makers (1894), naturally hagiographic, provides essential detail on the library’s origins and Lloyd’s chemical research but omits critical assessment of the eclectic movement’s failures.

See Also

• John King
• John Milton Scudder
• Eclectic Medicine
• Eclectic Medical Institute
• Lloyd Library and Museum
• Specific Medication
• Concentrated Medicines
• Whole-Plant Medicine
• Lloyd Brothers Pharmacists
• Andrew Jackson Howe

Sources